Sunday, July 3, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study elucidates importation risks and disproportionate spread of SARS-CoV-2 variants of concern in the Netherlands

by Medical Finance
in Coronavirus
Study: Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands. Image Credit: GoodStudio/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the medRxiv* pre-print server, researchers used whole-genome sequencing (WGS) to explore the transmission dynamics of four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) – Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2) in the Netherlands.

Study: Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands. Image Credit: GoodStudio/Shutterstock
Study: Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands. Image Credit: GoodStudio/Shutterstock

Background

In 2021, all the four VOCs were globally circulating, and they resurged coronavirus disease 2019 (COVID-19) outbreaks, impeding efforts to control the pandemic worldwide. Of these, the Alpha and Delta VOCs primarily dominated in the Netherlands. Hence, the Dutch government restricted flights from countries where Alpha and Delta had first emerged, simultaneously implementing several non-pharmaceutical interventions (NPIs) to mitigate their effect between 2020 and 2021.

More importantly, the government started a nationwide surveillance program and scaled up its WGS efforts for monitoring the introduction and spread of novel SARS-CoV-2 variants.

About the study

In the present study, spanning 48 weeks between September 2020 and August 2021, researchers sequenced randomly collected 39,844 high-quality SARS-CoV-2 whole genomes from the 1,792,759 laboratory-confirmed SARS-CoV-2-positive samples to characterize the importation risks and spread of Alpha, Beta, Gamma, and Delta VOCs in the Netherlands.

They used the NextClade lineage assignment to genotype the SARS-CoV-2-positive samples.

For a deeper insight into the overseas introduction of SARS-CoV-2 VOCs, the researchers subsampled a representative set of Dutch and overseas sequences collected within the same time frame. They reconstructed time-scaled, maximum likelihood (ML) phylogenies and used a Bayesian approach to perform distinct trait analyses on these fixed phylogeny trees.

They used a different set of Alpha and Delta WGS data for continuous phylogeographic analyses to estimate events of oversees introductions from other countries into the Netherlands for all the four VOCs to reconstruct the origin of ancestral strains.

Lastly, the research team fitted the weekly data of sampled VOCs to a logistic growth model for quantifying the growth rates of the Alpha and Delta VOCs in the Netherlands.

Study findings

The WGS genotyped most samples gathered during the starting phase of the study to clade 20A and its sublineages, 20B and 20E. The introduction of NPIs, such as closing nightlife establishments and restaurants in October 2020, reduced cases from these lineages circulating till December 2020 in the Netherlands.

The Netherlands imposed a nationwide lockdown after the first Alpha case, reported on December 5, 2020. Although the lockdown slightly decreased Alpha cases, it still became the dominant circulating SARS-CoV-2 VOC by February 2021, i.e., week 6 of the study period. Later, the Beta and Gamma VOCs were also identified via WGS efforts but did not outcompete Alpha.

When Alpha cases began to decline by the end of April 2021, the Dutch government began relaxing lockdown restrictions. Around the same time, WGS identified the first Delta case in the Netherlands, and by June 2021, the Delta VOC accounted for 24% of all sequenced genomes.

In June 2021, SARS-CoV-2 prevalence was lowest in the Netherlands, with only 8,690 SARS-CoV-2-positive cases. However, within a week of reopening, COVID-19 cases surged over 50,000 in weeks 26 and 27 (July 2021), and most were due to Delta. In just three weeks, Delta replaced Alpha as the dominant SARS-CoV-2 VOC in the Netherlands, with over 90% of surveilled genomes assigned to the Delta variant by mid-July 2021.  Additionally, the Delta cases rapidly surged inter-regionally in late June 2021, as indicated by a more than 400% estimated increase in total phylogenetic branch movements by July 2021. 

The study estimated that the most overseas introduction events for the ancestral strains were from Europe, and the Alpha, Beta, Gamma, and Delta VOCs accounted for 71%, 29%, 71%, 79% of these events, respectively. Notably, these European introductions continued to occur during the travel ban period in the Netherlands, suggesting the need for pan-European flight restrictions.

The researchers identified that the large, densely populated cities in the North Brabant, Utrecht, North and South Holland, also international and regional travel hubs of the Netherlands, formed the first (local) core cluster of dominant source locations in March 2020.

The Alpha and Delta VOCs were first detected in these locations and circulated mostly within these areas during the first four weeks after the introduction and dispersal to other regions was relatively less frequent. Later, bidirectional and asymmetric exchanges in phylogenetic branches between different regions emerged throughout the country amid strict lockdown.

Furthermore, the researchers observed that the Delta VOC showed a weekly growth rate of 103%, about two times higher than Alpha, which showed a weekly growth rate of 45%. Interestingly, Alpha and Delta replaced their predecessors rapidly with similar rates across most age groups.

Conclusions

The study highlighted that all the VOC lineages detected in the Netherlands before September 2020 until August 2021 originated mainly from its European neighbors. The very first introduction of SARS-CoV-2 in the Netherlands in February 2020 was due to travelers from Northern Italy, the seeding place of the earliest European SARS-CoV-2 transmission. Moreover, even after implementing international travel restrictions, the Netherlands remained highly vulnerable to importation risks of novel SARS-CoV-2 variants due to the European Union border policies.

The study findings highlight the need for continued surveillance of the cluster of locations where the VOCs were first detected to gather actionable information early on about the introduction of novel SARS-CoV-2 variants and timely containment of infections and onward transmission.

*Important notice

 medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Bats host the most virulent—but not the most dangerous—zoonotic viruses. Image Credit: shutter_o / Shutterstock.com

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

by Medical Finance
July 3, 2022
0

The current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a...

Lung abnormalities may remain detectable long after COVID-19 pneumonia

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

by Medical Finance
July 3, 2022
0

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania...

When teens blow off parents’ pleas to get vaccinated, the consequences can be deadly

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

by Medical Finance
July 3, 2022
0

Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes...

Study: Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting. Image Credit: Harry Wedzinga/Shutterstock

Scientists develop virus-blocking textile that effectively repulses SARS-CoV-2

by Medical Finance
July 3, 2022
0

In a recent study published Cell Reports Physical Science, scientists have described a virus-blocking textile that prevents transmission of severe...

Study: Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model. Image Credit: Vitalii Vodolazskyi/Shutterstock

Hypoxia-inducible factors and SARS-CoV-2 manifestations

by Medical Finance
July 3, 2022
0

A recent study posted to the bioRxiv* preprint server assessed the role of hypoxia-inducible factors (HIF) in severe acute respiratory...

Study: Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees. Image Credit: pancha.me/Shutterstock

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

by Medical Finance
July 3, 2022
0

In a recent study published in Emerging Infectious Diseases, researchers conducted a retrospective analysis to evaluate the duration of the...

Next Post
Study: BNT162b2 vaccine boosts neutralizing antibodies to ancestral SARS-CoV-2 & Omicron variant in adults received 2-dose inactivated vaccine. Image Credit: Tamer Adel Soliman/Shutterstock

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Study: Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants. Image Credit: Tatiana Shepeleva/Shutterstock

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Protein 620x480
    Orally-active senolytics can boost a key beneficial protein in mice and humans
  • Study: Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model. Image Credit: Vitalii Vodolazskyi/Shutterstock
    Hypoxia-inducible factors and SARS-CoV-2 manifestations
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply